Drug Hypersensitivity Research Grant
Forecasted
2027 Drug Hypersensitivity Research Grant supports researchers developing novel techniques, agents, methods, models, or applications to advance knowledge of drug allergy and hypersensitivity.
Funder: American Academy of Allergy, Asthma & Immunology (AAAAI)
Due Dates: October 12, 2026, at 3:00 pm Central Time (Application deadline)
Funding Amounts: Up to three research grants; funds support direct costs only
Summary: Supports research advancing knowledge of drug allergy and hypersensitivity through novel techniques, agents, methodologies, models, or applications.
Key Information: Applications focused on vaccine reactions will not be considered.
Description
The American Academy of Allergy, Asthma & Immunology (AAAAI) offers this grant to further research in drug allergy and hypersensitivity. The opportunity supports work that advances knowledge and develops novel techniques, agents, methodologies, models, or applications with the potential for a major impact on drug hypersensitivity research.
The program aligns with AAAAI’s broader mission to advance knowledge and practice in allergy, asthma, and immunology in support of optimal patient care. Potential research impact is central to the opportunity, and reviewers consider application quality and research-related activities in the context of this funding mechanism.
